PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL ...

Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced the enrollment of the first patient in a ...

According to the American College of Allergy Asthma and Immunology, nearly one in three U.S. adults report having a seasonal ...

Tumors develop when cells in the body grow uncontrollably. Finding a tumor on your dog can be very frightening, but they are ...

Jasper Therapeutics, Inc.’s JSPR share price has surged by 7.55%, which has investors questioning if this is right time to sell.

The CDC advises that if you see mold in your home, no matter what type it is, "you need to clean up the mold and fix the ...

Cogent Biosciences, Inc. topline results for phase 2/3 studies on bezuclastinib targeting systemic mastocytosis & GIST are ...

Learn more about whether Alvotech or Blueprint Medicines Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The traditional African diet is rich in vegetables, fruit, beans, wholegrains, and fermented foods, points out internist ...

In some cases, it can. Some dogs are less likely to have negative behaviors like marking territory and wandering. However, ...

The invention claims the use of Repirinast, either alone or in combination with telmisartan, for the treatment or prophylaxis of renal fibrosis or kidney disease ... manufacture a cGMP Repirinast ...